FDA Approves Papzimeos (zopapogene imadenovec-crba)

Aug 18, 2025

Papzimeos receives approval for adults with recurrent respiratory papillomatosis. This is a placeholder page; replace with full article content later.

← Back to Home
FDA Approves Dawnzena - PharmaOnline
Register

FDA Approves Dawnzena

FDA Approves Dawnzena (donidalorsen) as the First and Only RNA-targeted Prophylactic Treatment for Hereditary Angioedema

(BUSINESS WIRE)--Aug. 21, 2025-- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA)...